{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:18:56Z","timestamp":1789726736991,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals S.A."},{"DOI":"10.13039\/100009342","name":"AERAS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009342","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["tuberculosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.tube.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,8,9]],"date-time":"2014-08-09T21:30:25Z","timestamp":1407619825000},"page":"564-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial"],"prefix":"10.1016","volume":"94","author":[{"given":"Olubukola T.","family":"Idoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumuyiwa A.","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Owiafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderonke","family":"Odutola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bollaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Ogundare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Jongert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange","family":"Demoiti\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin O.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2014.07.001_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.tube.2014.07.001_bib2","series-title":"Global tuberculosis control: WHO report 2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.tube.2014.07.001_bib3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2014.07.001_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0962-8479(92)90043-J","article-title":"Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile","volume":"73","author":"Sepulveda","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.tube.2014.07.001_bib5","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2014.07.001_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2014.07.001_bib7","series-title":"Global tuberculosis program and global programme on vaccines: statement on BCG revaccination for the prevention of tuberculosis","first-page":"229","author":"World Health Organization","year":"1995"},{"key":"10.1016\/j.tube.2014.07.001_bib8","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2014.07.001_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel TB vaccine M72\/AS01 in South African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2014.07.001_bib10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s10875-013-9949-3","article-title":"A\u00a0randomized, controlled dose-finding phase II study of the M72\/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults","volume":"33","author":"Montoya","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib11","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib12","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","article-title":"Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family","volume":"67","author":"Dillon","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.07.001_bib13","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.07.001_bib14","series-title":"WHO global database on child growth and malnutrition","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.tube.2014.07.001_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline adjuvant systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Gar\u00e7on","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2014.07.001_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"Gar\u00e7on","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2014.07.001_bib17","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/INF.0b013e3181daf921","article-title":"Immunogenicity and safety of H5N1 A\/Vietnam\/1194\/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase II, randomized, open, controlled study","volume":"29","author":"D\u00edez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tube.2014.07.001_bib18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/656190","article-title":"Evaluation of the safety and immunogenicity of the RTS,S\/AS01E malaria candidate vaccine when integrated in the expanded program of immunization","volume":"202","author":"Agnandji","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2014.07.001_bib19","doi-asserted-by":"crossref","first-page":"88ra56","DOI":"10.1126\/scitranslmed.3002461","article-title":"Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants","volume":"3","author":"Ota","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2014.07.001_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2249.2005.02799.x","article-title":"T\u00a0cell-mediated immune responses in human newborns: ready to learn?","volume":"141","author":"Marchant","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/infdis\/jis941","article-title":"Longitudinal changes in CD4+ T-cell memory responses induced by BCG vaccination of newborns","volume":"207","author":"Soares","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2014.07.001_bib22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2014.07.001_bib23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2014.07.001_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG \u2013 implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2014.07.001_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2014.07.001_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clim.2005.10.012","article-title":"Innate cellular immune responses in newborns","volume":"118","author":"Mar\u00f3di","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib28","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.4049\/jimmunol.173.7.4627","article-title":"Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-\u03b1 induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848","volume":"173","author":"Levy","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib29","doi-asserted-by":"crossref","first-page":"781320","DOI":"10.1155\/2013\/781320","article-title":"Immune vulnerability of infants to tuberculosis","volume":"2013","author":"Vanden Driessche","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/erv.10.41","article-title":"The challenge of assessing infant vaccine responses in resource-poor settings","volume":"9","author":"Flanagan","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2014.07.001_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2172-6-13","article-title":"Standardization of cytokine flow cytometry assays","volume":"6","author":"Maecker","year":"2005","journal-title":"BMC Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-1759(98)00004-0","article-title":"Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry","volume":"212","author":"Suni","year":"1998","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.tube.2014.07.001_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1756-0500-6-120","article-title":"Comparison of whole blood and PBMC assays for T-cell functional analysis","volume":"6","author":"Deenadayalan","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.tube.2014.07.001_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/1043-4666(92)90062-V","article-title":"Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation","volume":"4","author":"De Groote","year":"1992","journal-title":"Cytokines"},{"key":"10.1016\/j.tube.2014.07.001_bib35","doi-asserted-by":"crossref","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2014.07.001_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2014.07.001_bib37","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstrom","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2014.07.001_bib38","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"The presence of multifunctional, high-cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J\u00a0Immunol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979214204227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979214204227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T02:48:03Z","timestamp":1649904483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979214204227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1472979214204227"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2014.07.001","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}